Keywords: oligonucleotide antisense; ANRIL; Antisense non-coding RNA in the INK4 locus; ASO; Antisense oligonucleotides; CRM1; Chromosome region maintenance 1; GAS5; Growth arrest-specific transcript 5; HOTAIR; Hox Transcript Antisense Intergenic RNA; mtDNAs; Mitochondrial DNAs; mtlncRNAs; M
مقالات ISI oligonucleotide antisense (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: oligonucleotide antisense; Genetic mutations; Genetic correction; Gene editing; Antisense oligonucleotides; Cardiomyopathy; Heart failure; Muscular dystrophy;
Keywords: oligonucleotide antisense; T1DM; Type 1 diabetes mellitus; EDS; Search E-Resources; IGF1; insulin-like growth factor 1; NOD; non-obese diabetic; G6Pase; glucose-6-phosphatase; HGF; hepatocyte growth factor; SCID; severe combined immunodeficiency; BTC; betacellulin; Ngn3; Neurogenin
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Liquid chromatography; Sample preparation; Protein precipitation; Enzyme digestion; Liquid-liquid extraction; Solid phase extraction;
Keywords: oligonucleotide antisense; Antisense oligonucleotides; PCSK9 inhibitors; Apolipoprotein CIII inhibitors; CETP inhibitors; Lp(a);
Keywords: oligonucleotide antisense; Myelodysplastic syndromes; Splicing factor genes; Mutations; RNA splicing; Splicing inhibitors; Antisense oligonucleotides;
Keywords: oligonucleotide antisense; ASO; antisense oligonucleotides; BANCR; BRAF-activated non-coding RNA; CCAT1-L; colorectal cancer associated transcript 1-long isoform; cET; constrained EThyl; EMT; epithelial to mesenchymal transition; ERV; endogenous retroviral sequence; FDA; food and d
Keywords: oligonucleotide antisense; MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: oligonucleotide antisense; Spinal muscular atrophy; Survival motor neuron; Valproic acid; Antisense oligonucleotides; Splice-switching oligonucleotides;
Keywords: oligonucleotide antisense; Antisense oligonucleotides; PEGylation; Disulfide bioconjugates; Solid phase synthesis; Gene silencing; ON; oligonucleotide; PEG; polyethylene glycol; CPG; controlled pore glass; LCAA; long chain amino alkyl; TCEP; tris(2-carboxyethyl)phosphin; TBP; tri-n
Keywords: oligonucleotide antisense; Cell-penetrating peptides; Nucleic acid delivery; Oligonucleotides; Antisense oligonucleotides; siRNA; Nanoparticles; Splice-switching oligonucleotides; Delivery peptides;
Keywords: oligonucleotide antisense; ABTS; azinobis(3-ethylbenzothiazoline-6-sulfonic acid); AD; Alzheimer's disease; AON; antisense oligonucleotides; AP; artificial peroxisome; AqpZ; aquaporin; BBB; blood-brain barrier; BSA; bovine serum albumin; CalB; candida antarctica lipase B; Cath B;
Keywords: oligonucleotide antisense; Familial hypercholesterolaemia; Genetic therapy; Antisense oligonucleotides; Apolipoprotein B; LDL receptor;
Keywords: oligonucleotide antisense; AAV; adeno-associated virus; ASO; antisense oligonucleotides; DBS; dried blood spot(s); DcPS; human scavenger decapping enzyme; DHPLC; denaturing high-performance liquid chromatography; HRMA; high-resolution melting analysis; LNA; lock nucleic acid; MLPA;
Keywords: oligonucleotide antisense; Cystic fibrosis; Cystic fibrosis transmembrane conductance regulator protein; CFTR2; Correctors; Potentiators; Trial end-points; Amil; Amiloride; AMP; Accelerating Medicine Partnership; ANO; anoctamins; AONs; antisense oligonucleotides; ASL; airway surfac
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Influenza virus; H1N1; Terminal modification;
Keywords: oligonucleotide antisense; Rare disease; Exon skipping; Splicing; Antisense oligonucleotides;
Keywords: oligonucleotide antisense; neurodegenerative disorder; proteinopathies; protein degradation; RNA interference; antisense oligonucleotides; high-throughput screening
Keywords: oligonucleotide antisense; Cx; connexin; HPV; human papilloma virus; NSHI; non-syndromic hearing impairment; ODDD; oculodentodigital dysplasia; ZO-1; zona occludens 1; E1 and E2; extracellular domains 1 and 2; PPK; palmoplantar hyperkeratinisation; KID; keratitis ichthyosis deafn
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Delivery; RNA interference; siRNA; microRNA; Neurodegeneration;
Keywords: oligonucleotide antisense; antisense oligonucleotides; apheresis; apolipoprotein B; cholesteryl ester transfer protein inhibitors; familial hypercholesterolemia; gene therapy; liver transplantation; low density lipoprotein cholesterol; microsomal triglyceride transfer protein inhib
Keywords: oligonucleotide antisense; ABC; adenosine triphosphate (ATP)-binding cassette; ASO; antisense oligonucleotides; CPT; camptothecin; DBD; drug-binding domain; DDS; drug delivery system; DOX; doxorubicin; EPR; enhanced permeability and retention effect; IC50 dose; a dose that kills 50
Keywords: oligonucleotide antisense; EGFR; Monoclonal antibodies; Tyrosine kinase inhibitors; Immunoconjugates; Antisense oligonucleotides; Cancer;
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Atomic force microscopy; Cationic lipids; Nanoemulsions; Energy dispersive X-ray diffraction; Phospholipids; X-ray diffractometry;
Keywords: oligonucleotide antisense; siRNA; small interfering RNA; AON; antisense oligonucleotides; shRNA; small hairpin RNA; pDNA; plasmid DNA; CYP3A; cytochrome P450 3A; MDR; multidrug resistance; MDR1; multidrug resistance protein 1; Pgp; P-glycoprotein; TRAIL; tumor necrosis factor-relat
Regulation of Tak1 alternative splicing by splice-switching oligonucleotides
Keywords: oligonucleotide antisense; Splice-switching oligonucleotides; Vivo-morpholino; Tak1; Isoform function; Lipid metabolism; 2OMePS; 2â²-O-methyl phosphorothioate; ALS; amyotrophic lateral sclerosis; AONs; Antisense oligonucleotides; AS; Alternative splicing; HFD; High-fat diet; NMD;
Generation of splice switching oligonucleotides targeting the Cockayne syndrome group B gene product in order to change the diseased cell state
Keywords: oligonucleotide antisense; DNA repair; Cockayne syndrome; UV sensitive syndrome; Antisense oligonucleotides; Exon skipping;
Activating frataxin expression by single-stranded siRNAs targeting the GAA repeat expansion
Keywords: oligonucleotide antisense; Friedreich's ataxia; Frataxin; Gene activation; ss-siRNAs; Antisense oligonucleotides;
Review on investigations of antisense oligonucleotides with the use of mass spectrometry
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Liquid chromatography; Mass spectrometry; Electrospray ionization; Matrix-assisted laser desorption ionization; Inductively coupled plasma;
Gene therapy with antisense oligonucleotides silencing c-myc reduces neointima formation and vessel wall thickness in a mouse model of vein graft disease
Keywords: oligonucleotide antisense; Coronary artery bypass grafting; Vein graft disease; Mouse model; Gene therapy; Antisense oligonucleotides; C-myc;
Antisense oligonucleotide therapy rescues disruptions in organization of exploratory movements associated with Usher syndrome type 1C in mice
Keywords: oligonucleotide antisense; Vestibular system; Visual system; Dead reckoning; Path integration; Spatial orientation; Home base; Pre-mRNA splicing; Antisense oligonucleotides; Usher syndrome; Harmonin; USH1C; Deafness;
Relationship between “LDL-C”, estimated true LDL-C, apolipoprotein B-100, and PCSK9 levels following lipoprotein(a) lowering with an antisense oligonucleotide
Keywords: oligonucleotide antisense; Lipoprotein(a); Low-density lipoprotein; Cholesterol; apoE polymorphisms; Proprotein convertase subtilisin kexin type 9; Antisense oligonucleotides;
Temporal variability in lipoprotein(a) levels in patients enrolled in the placebo arms of IONIS-APO(a)Rx and IONIS-APO(a)-LRx antisense oligonucleotide clinical trials
Keywords: oligonucleotide antisense; Lipoprotein(a); Isoforms; Single-nucleotide polymorphisms; Genetics; Cardiovascular events; Therapy; Antisense oligonucleotides;
Antisense-mediated reduction of EphA4 in the adult CNS does not improve the function of mice with amyotrophic lateral sclerosis
Keywords: oligonucleotide antisense; Amyotrophic lateral sclerosis; Ephrin receptor A4; Antisense oligonucleotides; Superoxide dismutase 1; Profilin 1;
Advances in the delivery of antisense oligonucleotides for combating bacterial infectious diseases
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Multidrug resistance; Drug delivery; Cell penetrating peptide; Nanoparticle;
Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Riskâ
Keywords: oligonucleotide antisense; antisense oligonucleotides; apolipoprotein C-II; apolipoprotein C-III; apolipoprotein E; LDL cholesterol; triglycerides;
Progress and promise of antisense oligonucleotide therapeutics for central nervous system diseases
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Drug development; CNS diseases;
Lipid-oligonucleotide conjugates improve cellular uptake and efficiency of TCTP-antisense in castration-resistant prostate cancer
Keywords: oligonucleotide antisense; Antisense oligonucleotides; TCTP; Castration resistant prostate cancer; Lipid modification; Drug delivery;
A novel penetratin-modified complex for noninvasive intraocular delivery of antisense oligonucleotides
Keywords: oligonucleotide antisense; Penetratin; Hyaluronic acid; Antisense oligonucleotides; Complex; Ocular gene delivery;
Dermal/transdermal delivery of small interfering RNA and antisense oligonucleotides- advances and hurdles
Keywords: oligonucleotide antisense; Small interfering RNA; Antisense oligonucleotides; Dermal; Transdermal; Iontophoresis; Microneedles;
miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells
Keywords: oligonucleotide antisense; Peptide-oligonucleotide conjugates; RNA cleavage; Antisense oligonucleotides; Anti-miRNA therapy; Oncogenic miRNA; miR-21;
The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia
Keywords: oligonucleotide antisense; Antisense oligonucleotides; Apolipoprotein C-III; Hypertriglyceridemia; IONIS-ApoCIIIRx; ISIS 304801; ISIS-ApoCIIIRx; Triglycerides; Volanesorsen;
Quantitative relationship between chemical properties and bioactivities of anti-microRNA oligonucleotides targeted to tumor-associated microRNA-21
Keywords: oligonucleotide antisense; microRNA-21; Antisense oligonucleotides; Cancer; Synthetic DNA;
Evolution, expression analysis, and functional verification of Catharanthus roseus RLK1-like kinase (CrRLK1L) family proteins in pear (Pyrus bretchneideri)
Keywords: oligonucleotide antisense; CrRLK1L; Catharanthus roseus RLK1-like kinases; RLKs; receptor-like kinases; PERKs; proline-rich extensin-like receptor-kinases; CRKs; cysteine-rich; LRR-RLKs; leucine-rich repeat RLKs; HERK1; HERCULES Receptor Kinase 1; RALFs; rapid alkalinization factor
Functions of microRNA-33a/b and microRNA therapeutics
Keywords: oligonucleotide antisense; ABCA1; HDL-C; Plaque; Antisense oligonucleotides
Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides
Keywords: oligonucleotide antisense; Antisense oligonucleotides; GalNAc; Asialoglycoprotein receptors; Bio-labile linker; Bridged nucleic acid; Locked nucleic acid; Apolipoproteins; Hypercholesterolemia
HDL and microRNA therapeutics in cardiovascular disease
Keywords: oligonucleotide antisense; ASO; antisense oligonucleotides; CAD; coronary artery disease; CVD; cardiovascular disease; DHCR7; 7-dehydrocholesterol reductase; HDL; high-density lipoproteins; HDL-C; HDL-cholesterol; HMGCS1; 3-hydroxy-3-methyl-glutaryl-CoA synthase 1; HMGCR; 3-hydroxy
RNA-targeted therapeutics in cancer clinical trials: Current status and future directions
Keywords: oligonucleotide antisense; Cancer clinical trials; RNA therapeutics; Antisense oligonucleotides; miRNA; siRNA
Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer
Keywords: oligonucleotide antisense; lncRNAs; Chromatin; Transcription regulation; Antisense oligonucleotides; Cancer
MicroRNAs and psychiatric disorders: From aetiology to treatment
Keywords: oligonucleotide antisense; MicroRNAs; Psychopathology; Gene regulation; Antidepressant drugs; Antipsychotic drugs; Biomarker; ADARs; adenosine deaminases acting on RNAs; Ago; argonaute; ASD; autism spectrum disorder; ASO; antisense oligonucleotides; circRNAs; circular RNAs; CSF; ce